Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Regorafenib is a valuable treatment option for metastatic colorectal cancer patients who have progressed after prior standard treatments. Prior progression-free survival data suggest that there could be a distinct subgroup of patients that may benefit from regorafenib. The aim of this study is to identify predictive biomarker of regorafenib in terms of its efficacy.
创建时间：
2013-10-15
